What to expect.
- Supports collagen production, the structural protein skin loses with age (GHK-Cu)
- Targets skin tone evenness and radiance at a systemic level
- Promotes tissue remodeling and skin renewal
- Supports deeper tissue repair and recovery beneath the surface (BPC-157 / TB-500)
- Contributes antioxidant and anti-inflammatory support for skin quality
- Formulated as an ongoing injectable protocol rather than a topical product

Dr. Taylor's take
“GHK-Cu is one of the most versatile tools I have for skin quality: the gene expression data on tissue remodeling is substantial. In Glow I pair it with BPC-157 and TB-500 so the protocol supports the repair happening beneath the skin at the same time. It is built for patients who want systemic skin support rather than another cream on the shelf.”
Dr. Patrick Taylor, MD · Live Vital physician
About Glow.
Glow is a physician-prescribed compounded blend of three peptides: GHK-Cu, a copper-binding tripeptide studied for its role in skin structure and tissue quality, alongside BPC-157 and TB-500, two peptides frequently prescribed together for tissue repair. Rather than treating the skin from the outside with a cream, Glow is formulated as an injectable so all three actives reach skin tissue systemically. GHK-Cu drives the tone and radiance effects at the surface level, while BPC-157 and TB-500 support the deeper tissue repair underneath.
GHK-Cu occurs naturally in the body and is found in blood, saliva, and urine, but levels fall substantially with age: plasma concentrations drop from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60. First isolated from human plasma by Dr. Loren Pickart in 1973, it has since been studied for its effects on collagen production, tissue remodeling, and antioxidant activity, which is why it is used widely in dermatology for skin quality support. BPC-157 is a 15-amino-acid peptide originally isolated from human gastric juice, and TB-500 is a synthetic version of thymosin beta-4, a protein naturally produced by the thymus gland; both support healing at the cellular level through complementary mechanisms.
How it works
GHK-Cu stimulates collagen and glycosaminoglycan synthesis and promotes proliferation of dermal fibroblasts, the cells responsible for rebuilding skin's structural matrix. Research on the peptide has also identified upregulation of thousands of genes tied to tissue remodeling and anti-inflammatory activity, alongside antioxidant effects that reduce oxidative damage in skin tissue over time.
BPC-157 and TB-500 complement this collagen-focused activity with repair mechanisms of their own. BPC-157 acts primarily at sites of tissue damage, promoting angiogenesis (new blood vessel formation) and growth factor activity, while TB-500 circulates systemically, upregulating actin to support cell migration and tissue remodeling. Administered together by injection, the blend supports skin tone, texture, and firmness from within while addressing the deeper repair that surface treatments cannot reach.
Who it may help.
- Individuals looking to improve skin tone evenness and radiance
- People interested in supporting collagen and skin structure as they age
- Those who prefer a systemic protocol over topical skincare products
- Individuals already established in a Live Vital skin-health protocol seeking a complementary option
What to expect, when.
Many patients report early changes in skin quality within the first few weeks, with tone and texture improvements typically building over a full three-month course as collagen remodeling progresses. As with any compounded therapy, individual response varies and outcomes are not guaranteed.
Dosing is not one-size-fits-all. Dr. Taylor personalizes your dose and schedule after your medical intake, and adjusts it as your protocol progresses.
Safety information.
Possible side effects
- Injection site redness or irritation
- Temporary skin discoloration (rare)
- Mild, transient skin irritation
- Nausea (rare)
- Headache (infrequent)
- Temporary fatigue
Who should talk to us first
- Active cancer or history of malignancy
- Known copper sensitivity or Wilson disease
- Pregnancy or breastfeeding
- Active infection at the injection site
- Active liver or kidney disease
- Concurrent use of anticoagulant medications without medical supervision
- Allergy to heavy metals
- Zinc or vitamin C deficiency
This information is educational and is not a substitute for medical advice. Every protocol requires a medical intake and physician approval, and outcomes vary by individual.
Standard with every plan.
Doctor-prescribed
Prescribed through Live Vital’s licensed clinical team.
Licensed US pharmacy
Prepared by a licensed US pharmacy and shipped to you.
Unlimited messaging
Reach our care team directly with questions at any time.